Search results for "Anesthesiology"

showing 10 items of 1218 documents

The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients

2012

Abstract OBJECTIVES: The aim of this study was to evaluate the opioid response in patients receiving morphine and pregabalin, independently from the presumed pain mechanisms, in comparison with patients receiving morphine treatment only. METHODS: A multicenter prospective randomized controlled study was carried out in a sample of 70 advanced cancer patients with pain requiring strong opioids. Thirty-five patients (group MO) were randomized to receive sustained-release morphine using initial doses of 60 mg/day. Thirty-five patients (group MO-PR) were randomized to start the same morphine doses and pregabalin in increasing doses, starting with 25 mg/day up to 150 mg/day in one week. The follo…

Malecancer painAnalgesicPregabalinPregabalinPainSettore MED/42 - Igiene Generale E Applicatalaw.inventionDose-Response Relationshipadvanced cancer patientDrug TherapyQuality of lifeRandomized controlled triallawassessment toolsNeoplasmsmedicineHumansDrug Interactionslow doses pregabalinBrief Pain Inventorygamma-Aminobutyric AcidPain Measurementneuropathic painAnalgesicsDose-Response Relationship DrugMorphinebusiness.industryassessment tools; cancer pain; neuropathic pain; opioid response; Analgesics; Dose-Response Relationship Drug; Drug Interactions; Drug Therapy Combination; Female; Humans; Italy; Male; Morphine; Neoplasms; Pain; Pain Measurement; Palliative Care; Pregabalin; Treatment Outcome; gamma-Aminobutyric Acid; Anesthesiology and Pain Medicine; Neurology (clinical)Palliative CareAdvanced cancerTreatment OutcomeAnesthesiology and Pain MedicineItalyOpioidlow doses pregabalin; advanced cancer patients; epidemiologic studyopioid responseAnesthesiaCombinationepidemiologic studyMorphineDrug Therapy CombinationFemaleNeurology (clinical)Drugbusinessmedicine.drug
researchProduct

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.

2006

Supplemental dosing of an opioid is the main treatment suggested to manage breakthrough pain in cancer patients. The intravenous route has been proven to be safe and effective, providing rapid analgesia in patients receiving oral morphine. Transdermal buprenorphine (TTS-BUP) is increasingly used in cancer pain management, but this drug has been labeled as a difficult drug to use in combination with other opioids. The aim of this open-label study was to verify the safety and effectiveness of intravenous morphine (IV-MO) for the treatment of episodic pain in cancer patients receiving TTS-BUP. A consecutive sample of 29 cancer patients, who were treated with TTS-BUP, reported an acceptable bas…

Malecancer painPalliative careExacerbationtransdermal buprenorphinePainOpioidAdministration CutaneousInjectionsNeoplasmsmedicineSecondary PreventionHumansepisodic breakthrough painDosingAdverse effectbreakthrough pain; cancer pain; Intravenous morphine; opioids; transdermal buprenorphine; Administration Cutaneous; Analgesics Opioid; Buprenorphine; Drug Combinations; Female; Humans; Injections Intravenous; Male; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Palliative Care; Secondary Prevention; Treatment Outcome; Anesthesiology and Pain Medicine; Neurology (clinical); Neurology; Nursing (all)2901 Nursing (miscellaneous)Nursing (all)2901 Nursing (miscellaneous)General NursingPain MeasurementAnalgesicsMorphinebusiness.industryPalliative CareopioidsIntravenous morphineMiddle Agedbreakthrough painBuprenorphineAnalgesics Opioidtransdermal buprenorphine.Drug CombinationsCutaneousAnesthesiology and Pain MedicineTreatment OutcomeNeurologyOpioidAnesthesiaAdministrationInjections IntravenousMorphineFemaleNeurology (clinical)IntravenousCancer painbusinesssafety and effectiveness of intravenous morphinemedicine.drugBuprenorphineJournal of pain and symptom management
researchProduct

Breakthrough pain in patients with abdominal cancer pain.

2014

Abstract OBJECTIVE: Characterization of breakthrough cancer pain (BTcP) in patients with abdominal cancer is lacking. The aim of this study was to assess the characteristics of BTcP in patients with abdominal cancer pain. PATIENTS AND METHODS: In an observational cohort study, from a consecutive sample of patients admitted to a pain relief and supportive care unit for a period of 13 months, patients with abdominal disease due to cancer, including primary cancer or metastases, were assessed for the presence of chronic abdominal pain; its mechanism, intensity of background pain, and pain flares, which were distinguishable from the baseline pain, were recorded. Patients presenting with pain fl…

Malecancer painmedicine.medical_specialtyPalliative careAnalgesicSettore MED/41 - AnestesiologiaDiseaseSettore MED/42 - Igiene Generale E ApplicataCohort StudiesNeoplasmsInternal medicinemedicineHumansPain ManagementIn patientcancer pain; breakthrough pain; abdominal pain; epidemiology; opioidsNeoplasm MetastasisAgedPain MeasurementAnalgesicsbusiness.industryPalliative Careabdominal painopioidsCancerbreakthrough painmedicine.diseaseAnesthesiology and Pain MedicineFemaleepidemiologyObservational studyNeurology (clinical)Chronic PainCancer painbusinessCohort study
researchProduct

Barriers and Adherence to Pain Management in Advanced Cancer Patients

2020

Aim To assess patients' barriers to pain management and analgesic medication adherence in patients with advanced cancer. Methods This was a prospective cross-sectional study in patients with advanced cancer receiving chronic opioid therapy. Age, gender, cancer diagnosis, Karnofsky level, and educational status were recorded. The Brief Pain Inventory (BPI), Edmonton Symptom Assessment Scale (ESAS), Memorial Delirium Assessment Scale (MDAS), Barriers Questionnaire II (BQ-II), Medication Adherence Rating Scale (MARS), and Hospital Anxiety and Depression Scale (HADS) were the measurement instruments used. Results One-hundred-thirteen patients were analyzed. The mean age was 68 (±13) years, and …

Malecancer painmedicine.medical_specialtyadherence to medicationPalliative careAnalgesicSettore MED/42 - Igiene Generale E ApplicataHospital Anxiety and Depression ScaleHealth Services Accessibility03 medical and health sciences0302 clinical medicine030202 anesthesiologyRating scaleNeoplasmsmedicineHumansPain ManagementProspective StudiesKarnofsky Performance StatusBrief Pain InventoryDepression (differential diagnoses)Agedpalliative carebusiness.industryCross-Sectional StudiesAnesthesiology and Pain MedicineopioidPhysical therapyPatient CompliancebarrierDeliriumFemalemedicine.symptombusinessCancer pain030217 neurology & neurosurgeryPain Practice
researchProduct

How do cancer patients receiving palliative care at home die? A descriptive study

2011

Abstract Context Data regarding the circumstances of the process of death of terminally ill patients followed at home are lacking. Objectives The aim of this study was to describe the characteristics and assess the circumstances of the process of death of terminally ill patients followed at home. Methods This was a prospective survey to assess the dying process of advanced cancer patients followed at home. Within a week after death, the principal caregiver was interviewed. Information from the palliative home care team and the caregiver about expectation of death, time of death, professional and nonprofessional people present at time of death, emergency admission to hospital, and administra…

Malecancer patientResuscitationmedicine.medical_specialtyPalliative careterminally ill patientsMEDLINEHome palliative careSettore MED/42 - Igiene Generale E ApplicataSocial classdeathCause of DeathNeoplasmsPhysicians80 and overMedicineHumansDeath rattleProspective StudiesProspective cohort studyGeneral NursingNursing (all)2901 Nursing (miscellaneous)Cause of deathAgedAged 80 and overTerminal Carebusiness.industrypalliative home carePalliative Caredeath; Home palliative care; terminally ill patients; Aged; Aged 80 and over; Cause of Death; Female; Home Care Services; Humans; Italy; Male; Middle Aged; Neoplasms; Palliative Care; Physicians; Prospective Studies; Social Class; Terminal Care; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)CancerMiddle Agedmedicine.diseaseHome Care ServicesAnesthesiology and Pain MedicineItalySocial Classdescriptive study.Emergency medicineFemaleMedical emergencyNeurology (clinical)medicine.symptombusiness
researchProduct

Children show hemispheric differences in the basic auditory response properties

2019

Auditory cortex in each hemisphere shows preference to sounds from the opposite hemifield in the auditory space. Besides this contralateral dominance, the auditory cortex shows functional and structural lateralization, presumably influencing the features of subsequent auditory processing. Children have been shown to differ from adults in the hemispheric balance of activation in higher-order auditory based tasks. We studied, first, whether the contralateral dominance can be detected in 7- to 8-year-old children and, second, whether the response properties of auditory cortex in children differ between hemispheres. Magnetoencephalography (MEG) responses to simple tones revealed adult-like cont…

Malecortical maturationMIDDLE-LATENCYAuditory responseLanguage functionLANGUAGEINFANTSAudiology3124 Neurology and psychiatryFunctional LateralityN100m0302 clinical medicineChild DevelopmentEVOKED-POTENTIALS10. No inequalityChildta515Research Articleselectromagnetic brain imagingMEGRadiological and Ultrasound Technologymedicine.diagnostic_test05 social sciencesAge FactorsMagnetoencephalographySPEECHkuuloNeurologyAuditory PerceptionEvoked Potentials AuditoryFemaleAnatomyPsychologyAdultmedicine.medical_specialtyEVENT-RELATED POTENTIALSlapset (ikäryhmät)Auditory cortexta3112MATURATION050105 experimental psychologyLateralization of brain function03 medical and health sciencesYoung AdultEvent-related potentialmedicineHumans0501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingSOURCE LOCALIZATIONdevelopmentAuditory Cortex3112 NeurosciencesMagnetoencephalographyNeurophysiology3126 Surgery anesthesiology intensive care radiologyaivokuoriN250mChild populationDEVELOPMENTAL-CHANGESNeurology (clinical)030217 neurology & neurosurgery
researchProduct

Impact of the Prone Position in an Animal Model of Unilateral Bacterial Pneumonia Undergoing Mechanical Ventilation

2013

Abstract Background: The prone position (PP) has proven beneficial in patients with severe lung injury subjected to mechanical ventilation (MV), especially in those with lobar involvement. We assessed the impact of PP on unilateral pneumonia in rabbits subjected to MV. Methods: After endobronchial challenge with Enterobacter aerogenes, adult rabbits were subjected to either “adverse” (peak inspiratory pressure = 30 cm H2O, zero end-expiratory pressure; n = 10) or “protective” (tidal volume = 8 ml/kg, 5 cm H2O positive end-expiratory pressure; n = 10) MV and then randomly kept supine or turned to the PP. Pneumonia was assessed 8 h later. Data are presented as median (interquartile range). Re…

Maleend-expiratory pressureSupine positionEndpoint Determinationmedicine.medical_treatmentrecruitment maneuverPeak inspiratory pressureLung injuryPulmonary compliancerabbit modelPositive-Pressure RespirationPneumonia BacterialProne PositionSupine PositionmedicineAnimalsratLungLung ComplianceTidal volumeInflammationMechanical ventilationrespiratory-distress-syndromecyclic stretchPulmonary Gas ExchangeTumor Necrosis Factor-alphabusiness.industryInterleukin-8Enterobacteriaceae InfectionsHemodynamicsEnterobacter aerogenesmedicine.diseaseRespiration ArtificialPneumoniaProne positiongas-exchangeAnesthesiology and Pain Medicineacute lung injuryAnesthesia[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieRabbitstidal volume ventilationbusinessair-space enlargementAnesthesiology
researchProduct

Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomiz…

2015

Fentanyl products have shown superiority to oral opioids for the management of breakthrough cancer pain (BTcP). However, these studies did not use appropriate patient selection, and drugs have been compared by using different rationales.The aim of this randomized, crossover, controlled study was to compare efficacy and safety of fentanyl buccal tablets (FBTs) and oral morphine (OM), given in doses proportional to opioid daily doses.Cancer patients with pain receiving ≥60 mg or more of oral morphine equivalents per day and presenting with ≤3 episodes of BTcP per day were included. In a randomized, crossover manner, patients received FBT or OM at doses proportional to the daily opioid regimen…

Malefentanyl buccal tabletContext (language use)FentanylNeoplasmsmedicineHumansCancer painGeneral NursingNursing (all)2901 Nursing (miscellaneous)Pain MeasurementCross-Over StudiesMorphinebusiness.industrybreakthrough pain; Cancer pain; fentanyl buccal tablet; oral morphine; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)Administration BuccalPatient PreferenceBuccal administrationMiddle Agedbreakthrough painCrossover studyAnalgesics OpioidFentanylRegimenTreatment OutcomeAnesthesiology and Pain MedicineOpioidoral morphineAnesthesiaMorphineFemaleNeurology (clinical)Cancer painbusinessmedicine.drug
researchProduct

Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A …

2016

Context Fentanyl products have shown superiority over oral opioids for the management of breakthrough cancer pain (BTcP). However, these studies did not use an appropriate patient selection, and drugs have been compared using a different rationale. Objectives The aim of this randomized, crossover, controlled study was to compare the efficacy and safety of fentanyl pectin nasal spray (FPNS) and oral morphine (OM), given in doses proportional to opioid daily doses. Methods Cancer patients with pain receiving ≥60 mg of OM equivalents/day and presenting with ≤3 episodes of BTcP/day were included. Patients received, in a randomized, crossover manner, FPNS or OM at doses proportional to the d…

Malefentanyl pectin nasal spraymedicine.medical_treatmentAdministration OralContext (language use)Fentanyl03 medical and health sciences0302 clinical medicinemedicineHumansCancer painGeneral NursingNursing (all)2901 Nursing (miscellaneous)Pain MeasurementAnalgesicsCross-Over StudiesMorphinebusiness.industryNasal SpraysMiddle Agedbreakthrough painCrossover studyFentanylRegimenTreatment OutcomeAnesthesiology and Pain MedicineOpioidNasal sprayoral morphine030220 oncology & carcinogenesisAnesthesiaMorphinePectinsFemaleNeurology (clinical)businessCancer painbreakthrough pain; Cancer pain; fentanyl pectin nasal spray; oral morphine; Nursing (all)2901 Nursing (miscellaneous); Neurology (clinical); Anesthesiology and Pain Medicine030217 neurology & neurosurgerymedicine.drug
researchProduct

Increased interleukin-6 and C-reactive protein levels after instrumented lumbar spine fusion in older patients

2019

Purpose: Interleukin 6 (IL-6) and the acute phase C-reactive protein (CRP) blood concentrations after lumbar spine fusion may be affected by age. The purpose of this prospective observational study was to assess postoperative serum levels of pro-inflammatory IL-6 and CRP after instrumented lumbar spine fusion surgery. We hypothesized that older patients would have increased levels of IL-6 and CRP after surgery. Methods: IL-6 and high-sensitive CRP biochemical marker levels were measured before instrumented spinal fusion, and postoperatively at 1 and 3 days, 6 weeks, and 3 months. The 49 patients in this sample were divided into two groups: age ≤ 60 years (n = 23) and age > 60 years (n = 26)…

MalefusionGastroenterologyleikkaushoitoDISEASEsurgery0302 clinical medicinePostoperative Complicationslcsh:Orthopedic surgeryOlder patientsMARKERSMedicinePostoperative PeriodProspective Studieskirurgiata315Aged 80 and over030222 orthopedicsLumbar VertebraebiologyAge FactorsMiddle AgedRECOVERYFemaleSpinal Diseasesmedicine.symptommusculoskeletal diseasesAdultmedicine.medical_specialtyLumbar spine fusionInflammationspinelannerankaC-reactive protein03 medical and health sciencesLumbarAGEselkärankaINFLAMMATIONc-reaktiivinen proteiiniInternal medicineINJURYHumansQUALITYInterleukin 6lumbarAgedbusiness.industryinterleukin-6DISABILITYC-reactive protein030229 sport sciences3126 Surgery anesthesiology intensive care radiologylcsh:RD701-811Spinal Fusionbiology.proteinbusinessBiomarkers
researchProduct